Pronóstico del mercado de descubrimiento de anticuerpos en Asia Pacífico hasta 2030: análisis regional, por tipo de anticuerpo (anticuerpos monoclonales, anticuerpos policlonales y otros), naturaleza (humano y humanizado, quimérico y murino), servicios (exhibición de fagos, hibridoma, animal transgénico, célula única y levadura) y usuario final (empresas farmacéuticas y de biotecnología, laboratorios de investigación y otros)
La proliferación de la industria biotecnológica en las regiones en desarrollo impulsa el mercado de descubrimiento de anticuerpos de Asia Pacífico
La notable precisión de los anticuerpos en la identificación de antígenos los convierte en herramientas invaluables para científicos y médicos. En la biotecnología moderna, los anticuerpos son necesarios en numerosos procesos, desde la investigación básica hasta las evaluaciones médicas innovadoras. El desarrollo de anticuerpos terapéuticos ha abierto nuevas vías en el tratamiento de diversas enfermedades, lo que demuestra la capacidad transformadora de estas partículas. Los anticuerpos también son cruciales en los diagnósticos basados en anticuerpos, ya que proporcionan enfoques precisos y confiables para la identificación de enfermedades. El creciente apoyo de los gobiernos, el aumento de las asociaciones público-privadas, los perfiles de enfermedades en constante cambio y el aumento de las actividades de financiación están mejorando ampliamente el rendimiento de las industrias de biotecnología en regiones como Asia Pacífico.
Según la Organización para la Cooperación y el Desarrollo Económicos (OCDE), China fue líder en términos de gasto en I+D en 2019. Las fuertes inversiones fomentan la adopción de tecnologías avanzadas en el sector de la salud. Los gobiernos de países de regiones como Asia ofrecen incentivos fiscales, tierras más baratas e inversiones directas para alentar a las empresas de biotecnología a expandir y fortalecer sus capacidades. Por lo tanto, países como Taiwán, Malasia, India, China, Singapur y Japón se encuentran entre los destinos más ventajosos para las industrias de biotecnología. Además, estos países asiáticos están más centrados en el uso de avances en genómica, proteómica y biomarcadores para aplicaciones diagnósticas y terapéuticas. Por lo tanto, se espera que la proliferación continua de industrias de biotecnología en regiones en desarrollo cree oportunidades para el mercado de descubrimiento de anticuerpos en los próximos años.
Resumen del mercado de descubrimiento de anticuerpos en Asia Pacífico
El mercado de descubrimiento de anticuerpos en Asia Pacífico está segmentado en China, Japón, India, Corea del Sur, Australia y el resto de Asia Pacífico. China representó la mayor participación del mercado en 2022, y se espera que India registre una CAGR significativa en el mercado durante el período de pronóstico. La industria biofarmacéutica en China está experimentando un cambio tremendo, evolucionando de un panorama centrado en los genéricos a un próspero centro de innovación. Además, el progreso en la industrialización y la aplicación de nuevos medicamentos, dispositivos médicos de alta gama y técnicas contribuyen al crecimiento del mercado de descubrimiento de anticuerpos en China.
China está experimentando un aumento en la prevalencia de enfermedades cardiovasculares y otras enfermedades crónicas. Según el Journal of Biomedical and Environmental Science, casi 330 millones de personas del país padecían enfermedades cardiovasculares en 2021. Los productos de anticuerpos son cruciales para el desarrollo de nuevas terapias contra las enfermedades cardiovasculares. Por lo tanto, una prevalencia creciente de enfermedades cardíacas desencadena la necesidad de descubrimiento de anticuerpos. Con la ayuda de los centros de investigación, se pueden investigar secuencias de anticuerpos, se pueden desarrollar anticuerpos nuevos y novedosos y se pueden optimizar los anticuerpos existentes. Según el Ranking del Instituto Scimago, China tenía casi 170 centros de investigación médica en 2022, seguida de Japón (72), Australia (53) e India (17). Además, el creciente número de actores del mercado que se centran en los países de Asia Pacífico para su expansión geográfica y otras estrategias de crecimiento, el creciente recuento de centros de investigación y un notable aumento de la financiación gubernamental impulsan el crecimiento del mercado de descubrimiento de anticuerpos en Asia Pacífico.
Ingresos y pronóstico del mercado de descubrimiento de anticuerpos de Asia Pacífico hasta 2030 (miles de millones de dólares estadounidenses)
Segmentación del mercado de descubrimiento de anticuerpos de Asia Pacífico
El mercado de descubrimiento de anticuerpos de Asia Pacífico se clasifica en tipo de anticuerpo, naturaleza, servicios, usuario final y país.
Según el tipo de anticuerpo, el mercado de descubrimiento de anticuerpos de Asia Pacífico se segmenta en anticuerpos monoclonales, anticuerpos policlonales y otros. El segmento de anticuerpos monoclonales tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de Asia Pacífico en 2022.
En términos de naturaleza, el mercado de descubrimiento de anticuerpos de Asia Pacífico se segmenta en humano y humanizado, quimérico y murino. El segmento humano y humanizado tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de Asia Pacífico en 2022.
Por servicios, el mercado de descubrimiento de anticuerpos de Asia Pacífico se divide en visualización de fagos, hibridoma, animal transgénico, célula única y visualización de levadura. El segmento de visualización de fagos tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de Asia Pacífico en 2022.
Según el usuario final, el mercado de descubrimiento de anticuerpos de Asia Pacífico se clasifica en empresas farmacéuticas y de biotecnología, laboratorios de investigación y otros. El segmento de empresas farmacéuticas y de biotecnología tuvo la mayor participación en el mercado de descubrimiento de anticuerpos de Asia Pacífico en 2022.
Según el país, el mercado de descubrimiento de anticuerpos de Asia Pacífico se clasifica en China, Japón, India, Corea del Sur, Australia y el resto de Asia Pacífico. China dominó la participación de mercado de descubrimiento de anticuerpos en Asia Pacífico en 2022.
Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp y Biocytogen Pharmaceuticals Beijing Co Ltd. son algunas de las empresas líderes que operan en el mercado de descubrimiento de anticuerpos de Asia Pacífico.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.1 Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Investments in Research & Development
4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
4.3.1 High Cost of Production
4.4 Market Opportunities
4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:
5. Antibody Discovery Market – Asia Pacific Market Analysis
5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020–2030
6. Asia Pacific Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Antibody Discovery Market – Country Analysis
10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Asia Pacific: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China
10.1.1.1.1 Overview
10.1.1.1.2 China: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Japan
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
10.1.1.3 India
10.1.1.3.1 Overview
10.1.1.3.2 India: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Australia
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
10.1.1.5 South Korea
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BioDuro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Twist Bioscience Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 16. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 17. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 18. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 19. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 20. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 21. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 22. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.